A Company which has:
1. Been granted approval to proceed with a Phase 3 trial in China
2. A Nicam portfolio "supposedly" testing positive anti-viral results
3. Been granted consent from the FDA to proceed with a Phase 3 trial in U.S.
4. Forcedly, been 'awarded' an arbitration ruling --- that fully funds previous Phase 3 trial by another company
5. Access to milions, when previous ruling, upholds agreement for sale of whorthless shares from treasury for .21 cents each.
6. Partner, 'supposedly' proceeding with trial, to fulfill "unresolved issues" required by FDA , EMA for another approval application for uveitis use.
AND YET, THE SHARE PRICE LINGERS NEAR WORTHLESS STATUS!!!!!!! YA! KEEP THE POSITIVE NEWS COMING!!!!! YA! BABY! YA!